Inflexxion® Inc. Unveils New NAVIPPRO™ Website

Inflexxion® Inc. announced today the launch of a new informational website to support its NAVIPPRO™ pharmaceutical risk management system at www.NAVIPPRO.com.

Newton, MA (PRWEB) April 21, 2008 -- Inflexxion® Inc. announced today the launch of a new informational website to support its NAVIPPRO™ pharmaceutical risk management system at www.NAVIPPRO.com. The National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO) is a unique, turnkey, multi-component solution that integrates sensitive national surveillance with sophisticated signal detection, signal verification, and targeted prevention and intervention programs. The website was designed by Inflexxion's in-house creative team.

"The NAVIPPRO.com website highlights our complete prescription opioid risk management solution and its scientific foundation. We believe NAVIPPRO can improve the public health through surveillance of prescription opioid abuse, and offer pharmaceutical companies comprehensive risk management for their products," explains Simon Budman, Ph.D., President, founder, and CEO of Inflexxion.

The newly designed website focuses on the four critical components of NAVIPPRO: surveillance, signal detection, signal verification, and intervention and prevention education programs. The website is designed to be an educational experience that provides a wide array of resources and information. Visitors can easily navigate through the site, subscribe to NAVIPPRO's quarterly e-newsletter, read about its distinguished Advisory Board, and download scientific publications written by Inflexxion researchers.

NAVIPPRO was developed in part with support from the National Institute on Drug Abuse. NAVIPPRO's founding industry sponsors include Alpharma Pharmaceuticals LLC., and Endo Pharmaceuticals.

# # #